Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for meta...

by A. Necchi, D. Raggi, M. Bandini, E. Farè, P. Giannatempo, M. Colecchia, F. Pederzoli, A. Gallina, L. Marandino, G. Calareso, R. Madison, A. Briganti, J. Ross, F. Montorsi
Published 2020-07-01

Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: evaluation of safety and efficacy of open and laparoscopic procedures

by N. Nicolai, S. Nazzani, M. Catanzaro, A. Tesone, A. Macchi, T. Torelli, S. Stagni, F. Celso, E. Agostini, M. Cloecchia, B. Avuzzi, R. Lanocita, A. Necchi, D. Raggi, P. Giannatempo, E. Farè, R. Salvioni, D. Biasoni
Published 2020-10-01

Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasiv...

by A. Necchi, D. Raggi, A. Briganti, E. Farè, P. Giannatempo, L. Marandino, A. Gallina, M. Colecchia, R. Lucianò, M. Bianchi, R. Colombo, A. Salonia, G. Gandaglia, N. Fossati, U. Capitanio, F. Montorsi, J. Boormans, Y. Liu, J. De Jong, R. Dittamore, E. Davicioni, P. Black, E. Gibb
Published 2020-07-01